Prestige BioPharma Limited (KRX:950210)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,990
+90 (0.65%)
At close: May 13, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is July - June.
Fiscal Year
FY 2024 FY 2023 FY 2019 FY 2018
Period Ending
Jun '24 Jun '23 Jun '19 Jun '18
Anti-cancer Drugs
689.73M
Log In
Log In
Log In
Anti-cancer Drugs Growth
325.85%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is July - June.
Fiscal Year
FY 2024 FY 2023 FY 2019 FY 2018
Period Ending
Jun '24 Jun '23 Jun '19 Jun '18
Singapore
689.73M
Log In
Log In
Log In
Singapore Growth
325.85%
Log In
Log In
Log In
South Korea
-
Log In
Log In
Log In